Compare INMD & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMD | CRON |
|---|---|---|
| Founded | 2008 | N/A |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 879.2M | 1.0B |
| IPO Year | 2019 | N/A |
| Metric | INMD | CRON |
|---|---|---|
| Price | $15.62 | $2.68 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.75 | N/A |
| AVG Volume (30 Days) | 563.3K | ★ 4.2M |
| Earning Date | 02-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.42 | N/A |
| EPS | ★ 2.21 | 0.09 |
| Revenue | ★ $364,494,000.00 | $132,357,000.00 |
| Revenue This Year | N/A | $17.63 |
| Revenue Next Year | $3.76 | $30.76 |
| P/E Ratio | ★ $7.03 | $28.57 |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $13.14 | $1.60 |
| 52 Week High | $19.78 | $3.43 |
| Indicator | INMD | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 71.55 | 47.94 |
| Support Level | $14.30 | $2.60 |
| Resistance Level | $14.96 | $2.73 |
| Average True Range (ATR) | 0.29 | 0.13 |
| MACD | 0.12 | -0.03 |
| Stochastic Oscillator | 92.61 | 9.86 |
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.